Showing results (331-340 of 719) with videos related to

Sort By:
Pageof 72
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1981
The effects of electrophoretically "slow" and "fast" alpha-2 macroglobulin on mixed lymphocyte culturesW J Hubbard, A D Hess, S Hsia, et al.
Transplantation|May 1, 1986
Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat modelG B Vogelsang, A D Hess, G Gordon, et al.
Cancer Research|April 1, 1986
Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding siteJ K Batra, L J Powers, F D Hess, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host diseaseA D Hess, C J Thoburn, W Chen, et al.
Oncogene|October 5, 1995
Enhanced p53 activity and accumulation in response to DNA damage upon DNA transfectionJ Siegel, M Fritsche, S Mai, et al.
Chest|August 1, 1996
Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brandD Hess, D Fisher, P Williams, et al.
Cancer Research|February 1, 1995
Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosisE J Fuchs, A Bedi, R J Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2004
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host diseaseChristopher J Thoburn, Yuji Miura, Emilie C Bright, et al.
Transplantation Proceedings|April 6, 2005
Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host diseaseA D Hess, C J Thoburn, Y Miura, et al.
The Journal of Experimental Medicine|April 1, 1985
Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivityA D Hess, L Horwitz, W E Beschorner, et al.
Pageof 72